Advertisement
OtherMINIREVIEWS

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794

Article Information

vol. 32 no. 11 1201-1208
DOI 
https://doi.org/10.1124/dmd.104.000794
PubMed 
15304429
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 1, 2004
  • Accepted August 9, 2004
  • Published online October 13, 2004.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. Andrew Williams,
  2. Ruth Hyland,
  3. Barry C. Jones,
  4. Dennis A. Smith,
  5. Susan Hurst,
  6. Theunis C. Goosen,
  7. Vincent Peterkin,
  8. Jeffrey R. Koup and
  9. Simon E. Ball
  1. Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Ann Arbor, Michigan (J.A.W, S.H., T.C.G., V.P., J.R.K., S.E.B.), and Sandwich, Kent, United Kingdom (R.H., B.C.G., D.A.S.)
  1. Address correspondence to:
    J. Andrew Williams, Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105. E-mail: james.williams2{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to November 2023

AbstractFullPdf
Aug 20175118772
Sep 20173114169
Oct 20176223294
Nov 20179022794
Dec 20175213659
Jan 20184519377
Feb 20185920977
Mar 20187327194
Apr 20183922258
May 20182623886
Jun 20183420859
Jul 20182818879
Aug 20183218566
Sep 201836204101
Oct 201838229102
Nov 201831207109
Dec 20182845354
Jan 20193203829
Feb 20192992029
Mar 20191914535
Apr 20193384339
May 20192753722
Jun 20192613936
Jul 20196202523
Aug 20197722927
Oct 20194024033
Nov 20192983825
Dec 20193114219
Jan 20202663813
Feb 20204213016
Mar 20205372911
May 202020343124
Jun 202015013725
Jul 202014621717
Aug 20209772116
Sep 20208534416
Oct 20207764021
Nov 20207203928
Dec 202015204611
Jan 2021134313536
Feb 2021107710226
Mar 202115516032
Apr 202114843726
May 202114146515
Jun 202114227617
Jul 20219554212
Aug 20217248318
Sep 20214515928
Oct 20215653619
Nov 20214853013
Dec 20213073213
Jan 20224083826
Feb 20223343611
Mar 20224043117
Apr 20223853517
May 20222633421
Jun 20222283513
Jul 20223263719
Aug 20221863912
Sep 20222114110
Oct 20222147415
Nov 20223144218
Dec 20222493622
Jan 20232916726
Feb 20233493931
Mar 20233703821
Apr 2023346368
May 20232917212
Jun 20232923618
Jul 20233683813
Aug 20234329718
Sep 20233963210
Oct 20234884329
Nov 20235873210

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMINIREVIEWS

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
Drug Metabolism and Disposition November 1, 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement